SOS vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

SOS

40.9
AI Score
VS
SOS Wins

CME

37.7
AI Score

Investment Advisor Scores

SOS

41score
Recommendation
HOLD

CME

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric SOS CME Winner
Forward P/E 0 21.7865 Tie
PEG Ratio 0 4.68 Tie
Revenue Growth -62.1% 0.8% CME
Earnings Growth 32.5% 2.5% SOS
Tradestie Score 40.9/100 37.7/100 SOS
Profit Margin -63.1% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL SOS

Relative Price Performance (Last 90 Days)

SOS 1M: -3.2% · 3M: -9.4% CME 1M: +8.1% · 3M: -4.9%

Current Technical Phase

SOS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.5 · Price: $0.99

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

Fundamentals Snapshot

Metric SOS CME
Market Cap
Forward P/E 0.0 21.3
Trailing P/E 22.6
Revenue (TTM)
Revenue Growth -0.6% 0.0%
Gross Margin 0.0% 1.0%
Operating Margin -1.3% 0.7%
EPS -6.42 11.97
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, SOS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.